{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T08:41:59Z","timestamp":1778661719405,"version":"3.51.4"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2009,6,4]],"date-time":"2009-06-04T00:00:00Z","timestamp":1244073600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2009,6,4]],"date-time":"2009-06-04T00:00:00Z","timestamp":1244073600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2009,10]]},"DOI":"10.1038\/leu.2009.100","type":"journal-article","created":{"date-parts":[[2009,6,4]],"date-time":"2009-06-04T09:43:45Z","timestamp":1244108625000},"page":"1836-1846","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":37,"title":["Interleukin-21 effectively induces apoptosis in mantle cell lymphoma through a STAT1-dependent mechanism"],"prefix":"10.1038","volume":"23","author":[{"given":"P","family":"Gelebart","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Z","family":"Zak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Anand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"Dien-Bard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H M","family":"Amin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R","family":"Lai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,6,4]]},"reference":[{"key":"BFleu2009100_CR1","first-page":"229","volume":"2","author":"SH Swerdlow","year":"2008","unstructured":"Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H et al. Classification of Tumours of Haematopoietic and Lymphoid Tissues, Fourth Edition. WHO Classification of Tumours, Volume 2 IARC 2008; 2: 229\u2013232.","journal-title":"WHO Classification of Tumours"},{"key":"BFleu2009100_CR2","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1097\/MOH.0b013e328302c9c5","volume":"15","author":"MR Smith","year":"2008","unstructured":"Smith MR . Mantle cell lymphoma: advances in biology and therapy. Curr Opin Hematol 2008; 15: 415\u2013421.","journal-title":"Curr Opin Hematol"},{"key":"BFleu2009100_CR3","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1038\/nrc2230","volume":"7","author":"P Jares","year":"2007","unstructured":"Jares P, Colomer D, Campo E . Genetic and molecular pathogenesis of mantle cell lymphoma: perspectives for new targeted therapeutics. Nat Rev Cancer 2007; 7: 750\u2013762.","journal-title":"Nat Rev Cancer"},{"key":"BFleu2009100_CR4","doi-asserted-by":"publisher","first-page":"88","DOI":"10.4049\/jimmunol.171.1.88","volume":"171","author":"LV Pham","year":"2003","unstructured":"Pham LV, Tamayo AT, Yoshimura LC, Lo P, Ford RJ . Inhibition of constitutive NF-kappa B activation in mantle cell lymphoma B cells leads to induction of cell cycle arrest and apoptosis. J Immunol 2003; 171: 88\u201395.","journal-title":"J Immunol"},{"key":"BFleu2009100_CR5","first-page":"8226","volume":"63","author":"N Martinez","year":"2003","unstructured":"Martinez N, Camacho FI, Algara P, Rodriguez A, Dopazo A, Ruiz-Ballesteros E et al. The molecular signature of mantle cell lymphoma reveals multiple signals favoring cell survival. Cancer Res 2003; 63: 8226\u20138232.","journal-title":"Cancer Res"},{"key":"BFleu2009100_CR6","doi-asserted-by":"publisher","first-page":"1923","DOI":"10.4049\/jimmunol.178.3.1923","volume":"178","author":"G Roue","year":"2007","unstructured":"Roue G, Perez-Galan P, Lopez-Guerra M, Villamor N, Campo E, Colomer D . Selective inhibition of IkappaB kinase sensitizes mantle cell lymphoma B cells to TRAIL by decreasing cellular FLIP level. J Immunol 2007; 178: 1923\u20131930.","journal-title":"J Immunol"},{"key":"BFleu2009100_CR7","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1016\/j.bcp.2005.04.043","volume":"70","author":"S Shishodia","year":"2005","unstructured":"Shishodia S, Amin HM, Lai R, Aggarwal BB . Curcumin (diferuloylmethane) inhibits constitutive NF-kappaB activation, induces G1\/S arrest, suppresses proliferation, and induces apoptosis in mantle cell lymphoma. Biochem Pharmacol 2005; 70: 700\u2013713.","journal-title":"Biochem Pharmacol"},{"key":"BFleu2009100_CR8","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1158\/1535-7163.MCT-07-0302","volume":"7","author":"CA Tucker","year":"2008","unstructured":"Tucker CA, Kapanen AI, Chikh G, Hoffman BG, Kyle AH, Wilson IM et al. Silencing Bcl-2 in models of mantle cell lymphoma is associated with decreases in cyclin D1, nuclear factor-kappaB, p53, bax, and p27 levels. Mol Cancer Ther 2008; 7: 749\u2013758.","journal-title":"Mol Cancer Ther"},{"key":"BFleu2009100_CR9","doi-asserted-by":"publisher","first-page":"4540","DOI":"10.1182\/blood-2005-10-4042","volume":"107","author":"L Fu","year":"2006","unstructured":"Fu L, Lin-Lee YC, Pham LV, Tamayo A, Yoshimura L, Ford RJ . Constitutive NF-kappaB and NFAT activation leads to stimulation of the BLyS survival pathway in aggressive B-cell lymphomas. Blood 2006; 107: 4540\u20134548.","journal-title":"Blood"},{"key":"BFleu2009100_CR10","doi-asserted-by":"publisher","first-page":"5142","DOI":"10.1182\/blood-2007-07-103481","volume":"111","author":"J Dal Col","year":"2008","unstructured":"Dal Col J, Zancai P, Terrin L, Guidoboni M, Ponzoni M, Pavan A et al. Distinct functional significance of Akt and mTOR constitutive activation in mantle cell lymphoma. Blood 2008; 111: 5142\u20135151.","journal-title":"Blood"},{"key":"BFleu2009100_CR11","doi-asserted-by":"publisher","first-page":"1668","DOI":"10.1182\/blood-2006-04-015586","volume":"108","author":"M Rudelius","year":"2006","unstructured":"Rudelius M, Pittaluga S, Nishizuka S, Pham TH, Fend F, Jaffe ES et al. Constitutive activation of Akt contributes to the pathogenesis and survival of mantle cell lymphoma. Blood 2006; 108: 1668\u20131676.","journal-title":"Blood"},{"key":"BFleu2009100_CR12","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1111\/j.1365-2141.2005.05630.x","volume":"130","author":"EG Rizzatti","year":"2005","unstructured":"Rizzatti EG, Falcao RP, Panepucci RA, Proto-Siqueira R, Anselmo-Lima WT, Okamoto OK et al. Gene expression profiling of mantle cell lymphoma cells reveals aberrant expression of genes from the PI3K-AKT, WNT and TGFbeta signalling pathways. Br J Haematol 2005; 130: 516\u2013526.","journal-title":"Br J Haematol"},{"key":"BFleu2009100_CR13","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1080\/10428190801910912","volume":"49","author":"EG Rizzatti","year":"2008","unstructured":"Rizzatti EG, Mora-Jensen H, Weniger MA, Gibellini F, Lee E, Daibata M et al. Noxa mediates bortezomib induced apoptosis in both sensitive and intrinsically resistant mantle cell lymphoma cells and this effect is independent of constitutive activity of the AKT and NF-kappaB pathways. Leuk Lymphoma 2008; 49: 798\u2013808.","journal-title":"Leuk Lymphoma"},{"key":"BFleu2009100_CR14","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1080\/10428190701851364","volume":"49","author":"S Gill","year":"2008","unstructured":"Gill S, Ritchie D . Therapeutic options in mantle cell lymphoma. Leuk Lymphoma 2008; 49: 398\u2013409.","journal-title":"Leuk Lymphoma"},{"key":"BFleu2009100_CR15","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1111\/j.0105-2896.2004.00201.x","volume":"202","author":"DS Mehta","year":"2004","unstructured":"Mehta DS, Wurster AL, Grusby MJ . Biology of IL-21 and the IL-21 receptor. Immunol Rev 2004; 202: 84\u201395.","journal-title":"Immunol Rev"},{"key":"BFleu2009100_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4049\/jimmunol.167.1.1","volume":"167","author":"H Asao","year":"2001","unstructured":"Asao H, Okuyama C, Kumaki S, Ishii N, Tsuchiya S, Foster D et al. Cutting edge: the common gamma-chain is an indispensable subunit of the IL-21 receptor complex. J Immunol 2001; 167: 1\u20135.","journal-title":"J Immunol"},{"key":"BFleu2009100_CR17","doi-asserted-by":"publisher","first-page":"8725","DOI":"10.1021\/bi0202023","volume":"41","author":"T Habib","year":"2002","unstructured":"Habib T, Senadheera S, Weinberg K, Kaushansky K . The common gamma chain (gamma c) is a required signaling component of the IL-21 receptor and supports IL-21-induced cell proliferation via JAK3. Biochemistry 2002; 41: 8725\u20138731.","journal-title":"Biochemistry"},{"key":"BFleu2009100_CR18","doi-asserted-by":"publisher","first-page":"4565","DOI":"10.1182\/blood-2002-04-1115","volume":"100","author":"A Suto","year":"2002","unstructured":"Suto A, Nakajima H, Hirose K, Suzuki K, Kagami S, Seto Y et al. Interleukin 21 prevents antigen-induced IgE production by inhibiting germ line C(epsilon) transcription of IL-4-stimulated B cells. Blood 2002; 100: 4565\u20134573.","journal-title":"Blood"},{"key":"BFleu2009100_CR19","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1016\/j.jaci.2003.08.039","volume":"112","author":"T Habib","year":"2003","unstructured":"Habib T, Nelson A, Kaushansky K . IL-21: a novel IL-2-family lymphokine that modulates B, T, and natural killer cell responses. J Allergy Clin Immunol 2003; 112: 1033\u20131045.","journal-title":"J Allergy Clin Immunol"},{"key":"BFleu2009100_CR20","doi-asserted-by":"publisher","first-page":"4111","DOI":"10.4049\/jimmunol.170.8.4111","volume":"170","author":"DS Mehta","year":"2003","unstructured":"Mehta DS, Wurster AL, Whitters MJ, Young DA, Collins M, Grusby MJ . IL-21 induces the apoptosis of resting and activated primary B cells. J Immunol 2003; 170: 4111\u20134118.","journal-title":"J Immunol"},{"key":"BFleu2009100_CR21","doi-asserted-by":"publisher","first-page":"5154","DOI":"10.4049\/jimmunol.172.9.5154","volume":"172","author":"J Pene","year":"2004","unstructured":"Pene J, Gauchat JF, Lecart S, Drouet E, Guglielmi P, Boulay V et al. Cutting edge: IL-21 is a switch factor for the production of IgG1 and IgG3 by human B cells. J Immunol 2004; 172: 5154\u20135157.","journal-title":"J Immunol"},{"key":"BFleu2009100_CR22","doi-asserted-by":"publisher","first-page":"4424","DOI":"10.1182\/blood-2008-02-135723","volume":"111","author":"JP Kolb","year":"2008","unstructured":"Kolb JP . IL-21 as new therapy for CLL? Blood 2008; 111: 4424\u20134425.","journal-title":"Blood"},{"key":"BFleu2009100_CR23","doi-asserted-by":"publisher","first-page":"4723","DOI":"10.1182\/blood-2007-07-099531","volume":"111","author":"A Gowda","year":"2008","unstructured":"Gowda A, Roda J, Hussain SR, Ramanunni A, Joshi T, Schmidt S et al. IL-21 mediates apoptosis through up-regulation of the BH3 family member BIM and enhances both direct and antibody-dependent cellular cytotoxicity in primary chronic lymphocytic leukemia cells in vitro. Blood 2008; 111: 4723\u20134730.","journal-title":"Blood"},{"key":"BFleu2009100_CR24","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.canlet.2007.06.001","volume":"256","author":"N Akamatsu","year":"2007","unstructured":"Akamatsu N, Yamada Y, Hasegawa H, Makabe K, Asano R, Kumagai I et al. High IL-21 receptor expression and apoptosis induction by IL-21 in follicular lymphoma. Cancer Lett 2007; 256: 196\u2013206.","journal-title":"Cancer Lett"},{"key":"BFleu2009100_CR25","doi-asserted-by":"publisher","first-page":"3756","DOI":"10.1182\/blood.V99.10.3756","volume":"99","author":"AT Brenne","year":"2002","unstructured":"Brenne AT, Ro TB, Waage A, Sundan A, Borset M, Hjorth-Hansen H . Interleukin-21 is a growth and survival factor for human myeloma cells. Blood 2002; 99: 3756\u20133762.","journal-title":"Blood"},{"key":"BFleu2009100_CR26","doi-asserted-by":"crossref","first-page":"424","DOI":"10.5858\/2003-127-0424-COMCLC","volume":"127","author":"HM Amin","year":"2003","unstructured":"Amin HM, McDonnell TJ, Medeiros LJ, Rassidakis GZ, Leventaki V, O\u2019Connor SL et al. Characterization of 4 mantle cell lymphoma cell lines. Arch Pathol Lab Med 2003; 127: 424\u2013431.","journal-title":"Arch Pathol Lab Med"},{"key":"BFleu2009100_CR27","first-page":"11","volume":"91","author":"I Salaverria","year":"2006","unstructured":"Salaverria I, Perez-Galan P, Colomer D, Campo E . Mantle cell lymphoma: from pathology and molecular pathogenesis to new therapeutic perspectives. Haematologica 2006; 91: 11\u201316.","journal-title":"Haematologica"},{"key":"BFleu2009100_CR28","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1038\/leu.2008.129","volume":"22","author":"JD Bard","year":"2008","unstructured":"Bard JD, Gelebart P, Anand M, Amin HM, Lai R . Aberrant expression of IL-22 receptor 1 and autocrine IL-22 stimulation contribute to tumorigenicity in ALK(+) anaplastic large cell lymphoma. Leukemia 2008; 22: 1595\u20131603.","journal-title":"Leukemia"},{"key":"BFleu2009100_CR29","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1084\/jem.181.5.1661","volume":"181","author":"N Zamzami","year":"1995","unstructured":"Zamzami N, Marchetti P, Castedo M, Zanin C, Vayssiere JL, Petit PX et al. Reduction in mitochondrial potential constitutes an early irreversible step of programmed lymphocyte death in vivo. J Exp Med 1995; 181: 1661\u20131672.","journal-title":"J Exp Med"},{"key":"BFleu2009100_CR30","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1111\/j.1365-2141.2004.05255.x","volume":"128","author":"M Ueda","year":"2005","unstructured":"Ueda M, Imada K, Imura A, Koga H, Hishizawa M, Uchiyama T . Expression of functional interleukin-21 receptor on adult T-cell leukaemia cells. Br J Haematol 2005; 128: 169\u2013176.","journal-title":"Br J Haematol"},{"key":"BFleu2009100_CR31","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1016\/j.cellsig.2006.09.003","volume":"19","author":"HS Kim","year":"2007","unstructured":"Kim HS, Lee MS . STAT1 as a key modulator of cell death. Cell Signal 2007; 19: 454\u2013465.","journal-title":"Cell Signal"},{"key":"BFleu2009100_CR32","doi-asserted-by":"publisher","first-page":"5236","DOI":"10.4049\/jimmunol.177.8.5236","volume":"177","author":"KL Good","year":"2006","unstructured":"Good KL, Bryant VL, Tangye SG . Kinetics of human B cell behavior and amplification of proliferative responses following stimulation with IL-21. J Immunol 2006; 177: 5236\u20135247.","journal-title":"J Immunol"},{"key":"BFleu2009100_CR33","doi-asserted-by":"publisher","first-page":"3596","DOI":"10.4049\/jimmunol.179.6.3596","volume":"179","author":"BR Barker","year":"2007","unstructured":"Barker BR, Parvani JG, Meyer D, Hey AS, Skak K, Letvin NL . IL-21 induces apoptosis of antigen-specific CD8+ T lymphocytes. J Immunol 2007; 179: 3596\u20133603.","journal-title":"J Immunol"},{"key":"BFleu2009100_CR34","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.canlet.2006.10.017","volume":"251","author":"DA Frank","year":"2007","unstructured":"Frank DA . STAT3 as a central mediator of neoplastic cellular transformation. Cancer Lett 2007; 251: 199\u2013210.","journal-title":"Cancer Lett"},{"key":"BFleu2009100_CR35","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1016\/S1074-7613(00)80152-1","volume":"11","author":"FX Pimentel-Muinos","year":"1999","unstructured":"Pimentel-Muinos FX, Seed B . Regulated commitment of TNF receptor signaling: a molecular switch for death or activation. Immunity 1999; 11: 783\u2013793.","journal-title":"Immunity"},{"key":"BFleu2009100_CR36","doi-asserted-by":"publisher","first-page":"6025","DOI":"10.4049\/jimmunol.166.10.6025","volume":"166","author":"A Jiang","year":"2001","unstructured":"Jiang A, Clark EA . Involvement of Bik, a proapoptotic member of the Bcl-2 family, in surface IgM-mediated B cell apoptosis. J Immunol 2001; 166: 6025\u20136033.","journal-title":"J Immunol"},{"key":"BFleu2009100_CR37","doi-asserted-by":"publisher","first-page":"9082","DOI":"10.1073\/pnas.97.16.9082","volume":"97","author":"RK Bruick","year":"2000","unstructured":"Bruick RK . Expression of the gene encoding the proapoptotic Nip3 protein is induced by hypoxia. Proc Natl Acad Sci USA 2000; 97: 9082\u20139087.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFleu2009100_CR38","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.1093\/emboj\/16.7.1686","volume":"16","author":"N Inohara","year":"1997","unstructured":"Inohara N, Ding L, Chen S, Nunez G . harakiri, a novel regulator of cell death, encodes a protein that activates apoptosis and interacts selectively with survival-promoting proteins Bcl-2 and Bcl-X(L). EMBO J 1997; 16: 1686\u20131694.","journal-title":"EMBO J"},{"key":"BFleu2009100_CR39","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/j.bbrc.2007.05.175","volume":"359","author":"X Zhao","year":"2007","unstructured":"Zhao X, Sun Y, Yu H, Ye L, Zhang L, Lu J et al. Apoptosis induced by BIK was decreased with RNA interference of caspase-12. Biochem Biophys Res Commun 2007; 359: 896\u2013901.","journal-title":"Biochem Biophys Res Commun"},{"key":"BFleu2009100_CR40","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1101\/gad.1522007","volume":"21","author":"T Shimazu","year":"2007","unstructured":"Shimazu T, Degenhardt K, Nur EKA, Zhang J, Yoshida T, Zhang Y et al. NBK\/BIK antagonizes MCL-1 and BCL-XL and activates BAK-mediated apoptosis in response to protein synthesis inhibition. Genes Dev 2007; 21: 929\u2013941.","journal-title":"Genes Dev"},{"key":"BFleu2009100_CR41","doi-asserted-by":"publisher","first-page":"4993","DOI":"10.1038\/sj.onc.1208683","volume":"24","author":"H Zhu","year":"2005","unstructured":"Zhu H, Zhang L, Dong F, Guo W, Wu S, Teraishi F et al. Bik\/NBK accumulation correlates with apoptosis-induction by bortezomib (PS-341, Velcade) and other proteasome inhibitors. Oncogene 2005; 24: 4993\u20134999.","journal-title":"Oncogene"},{"key":"BFleu2009100_CR42","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1002\/gcc.10245","volume":"38","author":"V Arena","year":"2003","unstructured":"Arena V, Martini M, Luongo M, Capelli A, Larocca LM . Mutations of the BIK gene in human peripheral B-cell lymphomas. Genes Chromosomes Cancer 2003; 38: 91\u201396.","journal-title":"Genes Chromosomes Cancer"},{"key":"BFleu2009100_CR43","doi-asserted-by":"publisher","first-page":"657","DOI":"10.4049\/jimmunol.173.1.657","volume":"173","author":"H Jin","year":"2004","unstructured":"Jin H, Carrio R, Yu A, Malek TR . Distinct activation signals determine whether IL-21 induces B cell costimulation, growth arrest, or Bim-dependent apoptosis. J Immunol 2004; 173: 657\u2013665.","journal-title":"J Immunol"},{"key":"BFleu2009100_CR44","doi-asserted-by":"publisher","first-page":"4163","DOI":"10.4049\/jimmunol.176.7.4163","volume":"176","author":"BR Herrin","year":"2006","unstructured":"Herrin BR, Justement LB . Expression of the adaptor protein hematopoietic Src homology 2 is up-regulated in response to stimuli that promote survival and differentiation of B cells. J Immunol 2006; 176: 4163\u20134172.","journal-title":"J Immunol"},{"key":"BFleu2009100_CR45","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1038\/sj.onc.1208300","volume":"24","author":"H Tagawa","year":"2005","unstructured":"Tagawa H, Karnan S, Suzuki R, Matsuo K, Zhang X, Ota A et al. Genome-wide array-based CGH for mantle cell lymphoma: identification of homozygous deletions of the proapoptotic gene BIM. Oncogene 2005; 24: 1348\u20131358.","journal-title":"Oncogene"},{"key":"BFleu2009100_CR46","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1089\/vim.2008.0025","volume":"21","author":"A Iannello","year":"2008","unstructured":"Iannello A, Tremblay C, Routy JP, Boulassel MR, Toma E, Ahmad A . Decreased levels of circulating IL-21 in HIV-infected AIDS patients: correlation with CD4+ T-cell counts. Viral Immunol 2008; 21: 385\u2013388.","journal-title":"Viral Immunol"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/leu2009100.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/leu2009100","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/leu2009100.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T12:15:42Z","timestamp":1648728942000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/leu2009100"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,6,4]]},"references-count":46,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2009,10]]}},"alternative-id":["BFleu2009100"],"URL":"https:\/\/doi.org\/10.1038\/leu.2009.100","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,6,4]]},"assertion":[{"value":"21 October 2008","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 February 2009","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2009","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2009","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}